Given that APE1 is overexpressed in PDAC (47) and G4s are known to regulate cancer driver genes (23), our findings also implicate that G4 can be considered as a novel prognostic marker and promising therapeutic target in PDAC. The gene discussed is APEX1; the disease is cancer.